Today: 13 June 2026
Mastercard stock slips with payments peers as year-end trading thins; MA eyes Fed minutes
30 December 2025
1 min read

Mastercard stock slips with payments peers as year-end trading thins; MA eyes Fed minutes

NEW YORK, December 29, 2025, 21:31 ET — Market closed

  • Mastercard ended down 0.3% on Monday, tracking a softer close for U.S. stocks into the final week of 2025.
  • Payment peers Visa and American Express also finished lower, keeping the group under pressure.
  • Traders are watching Fed meeting minutes and weekly jobless claims later this week for fresh clues on rates.

Mastercard Inc shares fell 0.3% to $577.90 on Monday, after trading between $577.01 and $581.99.

The move mattered because year-end liquidity is thinning, amplifying small shifts in risk appetite across large-cap stocks. Investors also start repositioning for January, when macro data and central bank signals typically regain control of price action.

For payments stocks, the rate outlook has become a near-term driver. Expectations for 2026 policy easing can support spending and travel volumes that generate fees for card networks, while higher yields can pressure equity valuations.

Wall Street’s main indexes ended lower, led by declines in heavyweight technology shares. “It’ll turn out to be a buying opportunity,” said Hank Smith, director and head of investment strategy at Haverford Trust. Minutes from the Fed’s previous meeting and weekly jobless claims were also on the radar in an otherwise light data week, the report said. Reuters

Mastercard’s pullback was in step with peers. Visa dipped 0.1% and American Express slid 1.5%.

Mastercard runs a global payments network and earns fees tied to purchase activity and cross-border transactions, which tend to move with travel and online commerce. Investors typically track volume metrics and pricing trends to gauge whether consumer demand is holding up.

In money markets, year-end funding dynamics drew attention on Monday. Federal Reserve data showed banks borrowed $25.95 billion via the standing repo facility, one of the highest daily totals since the program began in 2021.

Before the next session, traders will watch whether Tuesday’s early moves reinforce Monday’s cautious tone or reverse on thin flows. With the New Year holiday approaching, positioning and rate-sensitive sectors can swing quickly on modest headlines.

The next scheduled U.S. macro signposts include the Fed minutes and the weekly jobless-claims report later this week, which investors use as a fast read on labor conditions.

For Mastercard, the next company catalyst is its next earnings update and guidance. Nasdaq’s earnings calendar currently estimates a report around Jan. 29, though the date is not presented as company-confirmed.

On the chart, MA settled below $580 after testing above it during the session, leaving that round number as a near-term level traders are watching. Monday’s low near $577 marked the first visible support.

With the broader market nearing year-end and investors focused on the trajectory of Fed easing in 2026, Mastercard’s near-term direction is likely to hinge on rates and any read-through from labor data on consumer resilience.

Stock Market Today

  • Rezolve AI Plans $300 Million Buyback Amid Valuation Debate
    June 12, 2026, 6:08 PM EDT. Rezolve AI (RZLV) is under the spotlight after announcing a US$300 million share buyback funded from cash reserves. Trading at US$2.53, the stock gained 5.86% in one day but shows a 9.96% decline over 30 days. The company reaffirmed its 2026 revenue guidance and appointed a new Chief Marketing Officer, signaling confidence in growth. A popular market narrative values the stock at US$10.00, suggesting significant undervaluation, driven by potential recurring revenue growth and improved margins. However, risks around ambitious revenue targets and vendor integrations persist. Contrarily, some models, like Simply Wall St's discounted cash flow analysis, value the stock as low as US$0.15. Investors face a wide valuation gap, weighing Rezolve AI's future growth prospects against execution risks.

Latest articles

Alumis Shares Surge 16% as Traders Eye New Drug Move

Alumis Shares Surge 16% as Traders Eye New Drug Move

12 June 2026
Alumis soared 15.55% to $24.15 on double average volume after strong analyst support and late-stage psoriasis data, but remains a high-risk, loss-making biotech with no approved products; key investor focus is on Phase 2b lupus data due Q3 and a planned psoriasis NDA filing in Q4, with future stock moves hinging on these clinical and regulatory milestones.
Maase Shares Rise After Times Good Filing

Maase Shares Rise After Times Good Filing

12 June 2026
Maase Inc. (MAAS) jumped 15.73% to $14.86 after a June 12 SEC filing revealed its Times Good acquisition brings AI-computing revenue growth potential but also losses, negative cash flow, and a going-concern warning; investors await proof Maase can turn its AI push into funded projects and improved financials.
AMD stock today: Shares tick higher after hours as year-end tech selling weighs on chipmakers
Previous Story

AMD stock today: Shares tick higher after hours as year-end tech selling weighs on chipmakers

Orla Mining (ORLA) stock edges higher as gold rebounds; Fed minutes in focus
Next Story

Orla Mining (ORLA) stock edges higher as gold rebounds; Fed minutes in focus

Go toTop